CAN1012 in Pre-Malignant DCIS and LCIS

Clinical trial NCT07408856 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07408856
Sponsor: Providence Health & Services
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ductal Carcinoma in Situ Lobular Carcinoma in Situ

Start date: 2026-08-01
Primary completion: 2030-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.